Pfizer Inc
Pfizer Inc (PFE) Covered Calls
As of September 25, 2026, PFE has 114 covered call opportunities in the coming three months. Return ranges from 1.8 to 57.0% until expiration. Annualized return ranges from 7.3 to 323.7%. The nearest expiration is October 2, 2026. Maximum potential profit is $1,634.
Read more
Running PFE covered calls helps you generate consistent income from Pfizer Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Pfizer Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PFE covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PFE stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PFE covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Pfizer Inc covered call is worth writing.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands.
In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Income-focused investors, long-term PFE holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PFE covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Pfizer Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryDrug Manufacturers - General
- SectorHealthcare
- IV percentile77.78% Elevated
- Market cap (M$)163,410
- 52 weeks high-1.85%
- 52 weeks low21.43%
- Analyst recommendationHold
2.54 - Target price$28.57
-0.35% below the current stock price - Dividend—
- Payout ratio126.85%
- Earnings date2026-11-03
- P/E37.96
- Future P/E9.90
- EPS (ttm)0.76
- EPS growth next 5 years-8.26%
As of September 25, 2026
| 2026-10-16 | 21 | 34.00 | 18.59 | 0.01 | 0.02 | 534.00 | 18.63 | 323.73 | -0.03 | +0.02 | 654 | 0.01 |
| 2026-12-18 | 84 | 45.00 | 56.96 | 0.01 | 0.02 | 1634.00 | 56.99 | 247.65 | -0.03 | +0.01 | 17,918 | 0.01 |
| 2026-10-02 | 7 | 30.00 | 4.64 | 0.02 | 0.04 | 135.00 | 4.71 | 245.53 | -0.07 | +0.08 | 2,661 | 0.02 |
| 2026-11-20 | 56 | 39.00 | 36.03 | 0.01 | 0.04 | 1034.00 | 36.07 | 235.07 | -0.03 | +0.02 | 4,441 | 0.03 |
| 2026-10-16 | 21 | 32.00 | 11.61 | 0.01 | 0.05 | 334.00 | 11.65 | 202.48 | -0.03 | +0.04 | 1,969 | 0.04 |
| 2026-12-18 | 84 | 42.00 | 46.49 | 0.02 | 0.03 | 1335.00 | 46.56 | 202.33 | -0.07 | +0.02 | 1,101 | 0.01 |
| 2026-10-23 | 28 | 33.00 | 15.10 | 0.01 | 0.05 | 434.00 | 15.14 | 197.33 | -0.03 | +0.04 | 27 | 0.04 |
| 2026-10-16 | 21 | 31.50 | 9.87 | 0.02 | 0.05 | 285.00 | 9.94 | 172.78 | -0.07 | +0.05 | 6 | 0.03 |
| 2026-12-18 | 84 | 40.00 | 39.52 | 0.02 | 0.03 | 1135.00 | 39.59 | 172.02 | -0.07 | +0.02 | 22,578 | 0.01 |
| 2026-11-20 | 56 | 36.00 | 25.57 | 0.02 | 0.05 | 735.00 | 25.64 | 167.10 | -0.07 | +0.03 | 364 | 0.03 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best PFE covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→